Insulin Potentiation Therapy (IPT) is an alternative cancer treatment that uses insulin to potentiate the effects of chemotherapy drugs. The theory behind IPT is that cancer cells are more susceptible to chemotherapy drugs when insulin levels are temporarily lowered. During an IPT treatment, a patient is given a small dose of insulin, which causes a temporary drop in blood sugar levels. The patient is then given a lower amount of chemotherapy drugs, which are believed to be more effective due to the insulin-induced sensitivity of the cancer cells.
IPT is a more targeted and less toxic alternative to conventional chemotherapy, as lower doses of chemotherapy drugs can result in fewer side effects.
IPT is a bio-regenerative medicine procedure that uses a dose of fast-acting insulin as a biological response modifier to induce cell permeability in a controlled manner, thus facilitating the exchange between extra and intracellular fluids. Because it is metabolic-supported chemotherapy, it allows drugs to enter the cell interior, going to the specific site to generate a chemical and physical change that often contributes to repairing cell function.
